Virtus Biotech ETF-UsdBBPETF
13F holders, Q2 2025 (June 30)15holders +2
5new positions
3sold out
1famous investor
$58.28avg. 13F price*
At the end of Q2 2025, 15 institutions reported holding Virtus Biotech ETF-Usd Inc. (BBP) in their 13F filings, up 2 from Q1 2025. 5 opened new positions and 3 sold out. The largest holders were Susquehanna International Group, LLP ($1.7M), CWA Asset Management Group, LLC ($1.3M) and Jane Street Group, LLC ($1.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Virtus Biotech ETF-Usd Inc.
- Filed as
- ETFIS SER TR I (Q2 2025)
- CUSIP
- 26923G202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $3.5M |
| Exits | 3 | $244K |
All 13F filers, Q1 2025 → Q2 2025: 66,555 shares bought and 27,013 shares sold, net +39,542 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Susquehanna International Group, LLP | 0.00% | New | 28,503 | $1.7M |
| CWA Asset Management Group, LLC | 0.06% | Reduce -7.2% | 23,005 | $1.3M |
| Jane Street Group, LLC | 0.00% | New | 18,497 | $1.1M |
| Raymond James Financial Inc. | 0.00% | Reduce -29.7% | 17,433 | $1.0M |
| Morgan Stanley | 0.00% | Add +68.2% | 15,177 | $884K |
| Flow Traders U.S. LLC | 0.02% | New | 7,403 | $431K |
| Citadel Advisors | 0.00% | Reduce -41.7% | 7,119 | $415K |
| Independent Financial Group, LLC | 0.01% | Add +5.0% | 7,108 | $414K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 5,070 | $303K |
| Cetera Investment Advisers | 0.00% | Add +3.1% | 4,682 | $273K |
| LPL Financial LLC | 0.00% | Reduce -10.4% | 4,223 | $246K |
| Cwm, LLC | 0.00% | No change | 717 | $42K |
| Royal Bank of Canada | 0.00% | Reduce -93.4% | 571 | $33K |
| Osaic Holdings, Inc. | 0.00% | New | 450 | $26K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 50 | $3K |
"% of holder's portfolio" is BBP's weight in each manager's 13F, not the share of Virtus Biotech ETF-Usd Inc. the manager owns.